secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-01-24T23:59:59+00:00
Accession:  0001193125-24-013498
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q4 adj EPS $5.62 (+15.2% YoY); FY 2024 outlook above $37.10
---------------------------------------------------------------------------

- Q4 GAAP diluted EPS $3.63 (+1.1% YoY); adjusted diluted EPS $5.62 (+15.2% YoY).
- Q4 operating revenue $42.5B, up 7% YoY; full-year revenue $170.2B, up 9.3% YoY.
- FY 2024 guidance: GAAP EPS >$34.29, adjusted EPS >$37.10; quarterly dividend raised 10.1% to $1.63.
- Medical membership 47.0M, down 570k YoY from Medicaid redeterminations; Health Benefits operating gain +14% for the year.
- Operating cash flow $8.1B in 2023; repurchased 5.8M shares for $2.7B during the year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524013498/0001193125-24-013498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524013498/d736006d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-013498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer